Showing results (1-10 of 116) with videos related to
Sort By:
Pageof 12
Trends in Pharmacological Sciences|July 18, 2024
BTK inhibitors: past, present, and futureAllison Cool, Tiffany Nong, Skye Montoya, et al.Cells|August 28, 2024
Common Driver Mutations in AML: Biological Impact, Clinical Considerations, and Treatment StrategiesTiffany Nong, Shefali Mehra, Justin TaylorGenes|December 23, 2023
Resisting the Resistance: Navigating BTK Mutations in Chronic Lymphocytic Leukemia (CLL)Alexandra Chirino, Skye Montoya, Anita Safronenka, et al.Future Science OA|September 3, 2025
ChatGPT's role in the rapidly evolving hematologic cancer landscapeTiffany Nong, Sean Britton, Viralkumar Bhanderi, et al.Genes|September 27, 2025
Resistance Mutations in CLL: Genetic Mechanisms Shaping the Future of Targeted TherapySamantha Sekeres, Erica N Lamkin, Eduardo Bravo, et al.Biomedicines|November 27, 2021
Targeted Therapies in Cancer: To Be or Not to Be, SelectiveSkye Montoya, Deborah Soong, Nina Nguyen, et al.Leukemia Research Reports|August 21, 2025
Intercurrent presentation of hairy cell leukemia and diffuse large B-cell lymphoma with hemophagocytic lymphohistiocytosis: a case reportTiffany Nong, Xiaoqiong Wang, Wenhui Li, et al.Future Oncology (London, England)|October 3, 2025
Pirtobrutinib in the treatment of chronic lymphocytic leukemia or small lymphocytic lymphomaSyed Ibrahim, Nghia Pham, Aarushi Sahni, et al.Leukemia Research|January 25, 2023
Therapy-selected clonal hematopoiesis and its role in myeloid neoplasmsJacob Jahn, Benjamin Diamond, Jeffrey Hsu, et al.Cancers|July 29, 2023
Non-Covalent Bruton's Tyrosine Kinase Inhibitors in the Treatment of Chronic Lymphocytic LeukemiaSkye Montoya, Meghan C ThompsonPageof 12